Katherine Fernandez, NP
Nurse Practitioner · Fort Wayne, INNPI 1285353979
Payments from drug & device makers
Across 136 payments — averaging $24.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$689
- Sumitomo Pharma America, Inc.$454
- AbbVie$384
- Lilly USA, LLC$287
- Novo Nordisk$161
- AstraZeneca$137
- plus $1K from 27 others
What the payments were for
- Travel & lodging$55716%
- Food & beverage$2,75682%
- Education$682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 6 | $689 |
| Sumitomo Pharma America, Inc. | 36 | $454 |
| AbbVie | 20 | $384 |
| Lilly USA, LLC | 11 | $287 |
| Novo Nordisk | 8 | $161 |
| AstraZeneca | 3 | $137 |
| Endo USA, Inc. | 2 | $125 |
| Pfizer | 6 | $106 |
| Phathom Pharmaceuticals, Inc. | 1 | $95 |
| Axsome Therapeutics, Inc. | 4 | $91 |
| Astellas Pharma US Inc | 2 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $65 |
| Corium, LLC | 3 | $58 |
| Xeris Pharmaceuticals, Inc. | 3 | $54 |
| Bayer | 2 | $45 |
| Medtronic | 1 | $42 |
| Lundbeck LLC | 2 | $42 |
| Boehringer Ingelheim | 2 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $40 |
| Merck | 2 | $36 |
| 180 Medical, Inc. | 1 | $29 |
| Amgen | 2 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Urogen Pharma, Inc. | 1 | $27 |
| Dentsply IH AB | 1 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Exact Sciences | 1 | $21 |
| Novartis | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Shield Therapeutics Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AdVance XP$557
- MOUNJARO$122
- GEMTESA$118
- FARXIGA$107
How this compares
$3,380 in reported general payments places this provider in the 90th percentile of 2,724 nurse practitioner providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 19 | $29,559 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $24,403 |
| OzempicSemaglutide | 11 | $11,607 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 66 | $828 |
| Famotidine | 47 | $753 |
| Duloxetine Hcl | 17 | $664 |
| Pantoprazole Sodium | 57 | $627 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $556 |
| Gabapentin | 25 | $490 |
| Omeprazole | 25 | $437 |
| Levothyroxine Sodium | 50 | $364 |
| Hydroxyzine Hcl | 32 | $302 |
| Atorvastatin Calcium | 40 | $283 |
| Pravastatin Sodium | 24 | $275 |
| Bupropion XlBupropion Hcl | 19 | $240 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $287 | $29,55919 claims |
| Novo NordiskOzempic | $161 | $11,60711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 nurse practitioner providers in Indiana.
Other nurse practitioner in Fort Wayne
- Sean GoddardFort Wayne$180K
- Kristine TaylorFort Wayne$69K
- Mary BullisFort Wayne$27K
- Nathan MinerFort Wayne$21K
- Joel NagelFort Wayne$20K
- Gabriela NorthFort Wayne$18K
- Karen LothamerFort Wayne$12K
- Pamela ShodaFort Wayne$11K
- Sara CoburnFort Wayne$9K
- Marlise FletterFort Wayne$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.